

COVID-19 Rapid Antigen Test Kits Market Scope:
Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
The COVID-19 Rapid Antigen Test Kits market is experiencing significant growth, driven by the ongoing demand for quick and accurate diagnostic solutions. The market size is projected to reach approximately $5 billion by 2025, fueled by increased testing initiatives and rising consumer awareness of rapid testing accessibility amid pandemic conditions. Request Sample Report
◍ Abbott
◍ AESKU.GROUP
◍ ARISTA® Biotech
◍ IHealth
◍ Quidel
◍ ACCESS BIO
◍ ROCHE DIAGNOSTICS
◍ Artron Laboratories
◍ Philosys
◍ Innovation Scientific
◍ CTK Biotech
◍ GenBody Inc
◍ SD Biosensor
◍ JOYSBIO
◍ Medriva
◍ AUISET
◍ Biotest Biotech
◍ Hangzhou AllTest Biotech
The COVID-19 Rapid Antigen Test Kits Market is competitive, featuring companies like Abbott, Quidel, and Roche Diagnostics, which drive innovation and accessibility. These firms enhance market growth through diverse product offerings and strategic partnerships. Some sales revenues include:
- Abbott: $1.5 billion in test kit sales
- Quidel: $1.2 billion in revenue
Request Sample Report
Hospital
Company
School
Home
Others
◍ Nasopharyngeal Swab
Nasal Swab
Oropharyngeal Swab
Saliva Swab
Request Sample Report
Request Sample Report
$ X Billion USD